Influence of adjuvants on murine immune responses against the C‐terminal 19 kDa fragment of Plasmodium vivax merozoite surface protein‐1 (MSP‐1)

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Parasite immunology (Print)

• Publication date

  1996-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1365-3024.1996.d01-32.xPMID 9226693
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunoglobulin G2a isotype may have a protective role inPlasmodium berghei NK65 infection in immunised mice

  2004cited by this paper
• Expression and immunogenicity of the C-terminus of a major blood-stage surface protein of Plasmodium vivax, Pv200(19), secreted from Saccharomyces cerevisiae.

  1996cited by this paper
• Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1

  1996cited by this paper
• Epitopes in the 19kDa fragment of the Plasmodium falciparum major merozoite surface protein‐1 (PfMSP‐119) recognized by human antibodies

  1995cited by this paper
• Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria.

  1995cited by this paper
• Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants.

  1995cited by this paper
• Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1.

  1995cited by this paper
• A new polymorphic marker for PCR typing of Plasmodium vivax parasites.

  1995cited by this paper
• Copolymer adjuvants in malaria vaccine development.

  1994cited by this paper
• Immunization against malaria with a recombinant protein

  1994cited by this paper
• Expression and antigenicity of Plasmodium falciparum major merozoite surface protein (MSP1(19)) variants secreted from Saccharomyces cerevisiae.

  1994cited by this paper
• Immunogenicity of the C-terminal 19-kDa fragment of the Plasmodium falciparum merozoite surface protein 1 (MSP1), YMSP1(19) expressed in S. cerevisiae.

  1994cited by this paper
• Immunity to erythrocytic stages of malarial parasites.

  1994cited by this paper
• The potential for recruiting immune responses toward type 1 or type 2 T cell help.

  1994cited by this paper
• The role of TH1 and TH2 cells in a rodent malaria infection.

  1993cited by this paper
• Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1.

  1993cited by this paper
• Immunological cross-reactivity of the C-terminal 42-kilodalton fragment of Plasmodium falciparum merozoite surface protein 1 expressed in baculovirus

  1993cited by this paper
• Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines.

  1993cited by this paper
• A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice

  1993cited by this paper
• Structure and expression of the gene for Pv200, a major blood-stage surface antigen of Plasmodium vivax.

  1992cited by this paper
• Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA 1.

  1992cited by this paper
• Use of glass beads and CF 11 cellulose for removal of leukocytes from malaria-infected human blood in field settings.

  1992cited by this paper
• A reticulocyte-binding protein complex of Plasmodium vivax merozoites.

  1992cited by this paper
• A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth.

  1992cited by this paper
• Cloning of the Plasmodium vivax Duffy receptor.

  1991cited by this paper
• Adjuvant activity of non-ionic block copolymers. V. Modulation of antibody isotype by lipopolysaccharides, lipid A and precursors.

  1991cited by this paper
• Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species.

  1991cited by this paper
• Immunogenicity of Streptococcus pneumoniae type 14 capsular polysaccharide: influence of carriers and adjuvants on isotype distribution

  1991cited by this paper
• Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains.

  1991cited by this paper
• Murine IgG isotype responses to the Plasmodium cynomolgi circumsporozoite peptide (NAGG)5. I. Effects of carrier, copolymer adjuvants, and lipopolysaccharide on isotype selection.

  1991cited by this paper
• Influence of adjuvants on the antibody specificity to the Plasmodium falciparum major merozoite surface protein, gp195.

  1991cited by this paper
• A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion- inhibiting antibodies

  1990cited by this paper
• The many faces of epidermal growth factor repeats.

  1990cited by this paper
• Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies.

  1989cited by this paper
• A protective monoclonal antibody recognizes a variant-specific epitope in the precursor of the major merozoite surface antigen of the rodent malarial parasite Plasmodium yoelii.

  1989cited by this paper
• The precursor to major merozoite surface antigens: structure and role in immunity.

  1988cited by this paper
• Characterization with monoclonal antibodies of a surface antigen of Plasmodium falciparum merozoites.

  1985cited by this paper
• Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immunodominant epitope.

  1985cited by this paper
• Passive immunization against murine malaria with an IgG3 monoclonal antibody.

  1984cited by this paper

• A chimeric protein-based malaria vaccine candidate induces A chimeric protein-based malaria vaccine candidate induces robust T cell responses against Plasmodium vivax MSP119 robust T cell responses against Plasmodium vivax MSP119

  2021cites this paper
• Immunogenicity of a plasmid DNA vaccine encoding 42kDa fragment of Plasmodium vivax merozoite surface protein-1.

  2016cites this paper
• A chimeric protein-based malaria vaccine candidate induces robust T cell responses against Plasmodium vivax MSP119

  2016cites this paper
• Experimental Immunization Based on Plasmodium Antigens Isolated by Antibody Affinity

  2015cites this paper
• Cloning, overexpression and characterization of soluble 42kDa fragment of merozoite surface protein-1 of Plasmodium vivax.

  2014cites this paper
• Efficacy of the merozoite surface protein 1 of Plasmodium vivax as an antigen for ELISA to diagnose malaria.

  2004cites this paper
• Comparison of Immunogenicities of Recombinant Plasmodium vivax Merozoite Surface Protein 1 19- and 42-Kilodalton Fragments Expressed in Escherichia coli

  2004cites this paper
• Splenectomised and spleen intact Aotus monkeys' immune response to Plasmodium vivax MSP-1 protein fragments and their high activity binding peptides.

  2003cites this paper
• Adjuvants and malaria vaccine development.

  2002cites this paper
• Efficacy of vaccines containing rhoptry-associated proteins RAP1 and RAP2 of Plasmodium falciparum in Saimiri boliviensis monkeys.

  2000cites this paper
• Influence of antigenic forms and adjuvants on protection against a lethal infection of Aujeszky's disease virus.

  2000cites this paper
• Linkage of Exogenous T-cell Epitopes to the 19-Kilodalton Region of Plasmodium yoelii Merozoite Surface Protein 1 (MSP119) Can Enhance Protective Immunity against Malaria and Modulate the Immunoglobulin Subclass Response to MSP119

  2000cites this paper
• Partial Protection against Plasmodium vivaxBlood-Stage Infection in Saimiri Monkeys by Immunization with a Recombinant C-Terminal Fragment of Merozoite Surface Protein 1 in Block Copolymer Adjuvant

  1999cites this paper
• Influence of antigenic forms and adjuvants on the IgG subclass antibody response to Aujeszky's disease virus in mice.

  1999cites this paper
• Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin.

  1997cites this paper
• Immunity to infection

  1997cites this paper